Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
90 CHF | +0.99% | +6.50% | +6.06% |
Apr. 24 | BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating | MT |
Apr. 24 | Novartis Says New Malaria Drug Formulation Safe and Effective for Babies | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.06% | 199B | |
+24.17% | 562B | |
-6.36% | 358B | |
+18.59% | 322B | |
+7.31% | 297B | |
+13.98% | 219B | |
-10.35% | 196B | |
-11.25% | 149B | |
-7.16% | 146B | |
+1.95% | 117B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- NOVARTIS AG : Goldman Sachs remains its Buy rating